OUTLOOK THERAPEUTICS Trademark

Trademark Overview

On Tuesday, November 20, 2018, a trademark application was filed for OUTLOOK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OUTLOOK THERAPEUTICS trademark a serial number of 88201811. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2022. This trademark is owned by Oncobiologics, Inc.. The OUTLOOK THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
outlook therapeutics

General Information

Serial Number88201811
Word MarkOUTLOOK THERAPEUTICS
Filing DateTuesday, November 20, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Goods and Servicespharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 10, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOUTLOOK THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCRANBURY, NJ 08512
Party NameOncobiologics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512
Party NameOncobiologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events

Event DateEvent Description
Monday, August 1, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 1, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 3, 2022SOU EXTENSION 5 GRANTED
Friday, December 17, 2021SOU EXTENSION 5 FILED
Friday, December 17, 2021TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 20, 2021SOU EXTENSION 4 GRANTED
Sunday, June 20, 2021SOU EXTENSION 4 FILED
Sunday, June 20, 2021TEAS EXTENSION RECEIVED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 10, 2020SOU EXTENSION 3 GRANTED
Thursday, December 10, 2020SOU EXTENSION 3 FILED
Thursday, December 10, 2020TEAS EXTENSION RECEIVED
Thursday, June 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 9, 2020SOU EXTENSION 2 GRANTED
Tuesday, June 9, 2020SOU EXTENSION 2 FILED
Tuesday, June 9, 2020TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020SOU EXTENSION 1 GRANTED
Friday, December 20, 2019SOU EXTENSION 1 FILED
Monday, January 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 1, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, December 20, 2019TEAS EXTENSION RECEIVED
Wednesday, December 18, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 22, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 22, 2019ASSIGNED TO LIE
Wednesday, February 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 26, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, February 26, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 26, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, February 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 22, 2019ASSIGNED TO EXAMINER
Monday, December 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 23, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics outlook retinal disease treatment drugs namely ophthalmic pharmaceuticals